Ariel Perez Selected Research

Ariel Perez Research Topics

3	Neoplasms (Cancer) 08/2023 - 07/2020
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2023 - 01/2021
2	Inflammation (Inflammations) 08/2023 - 12/2021
2	Neutropenia 01/2022 - 12/2021
2	cell-associated neurotoxicity 12/2021 - 01/2021
2	Cytokine Release Syndrome 12/2021 - 01/2021
1	Cytopenia 01/2023
1	Infections 01/2022
1	Lymphoma (Lymphomas) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2020
1	Stiff-Person Syndrome (Stiff Man Syndrome) 08/2019
1	Adenocarcinoma of Lung 08/2019
1	Hemorrhage 03/2018
1	Hypoprothrombinemias (Prothrombin Deficiency) 03/2018
1	Disease Susceptibility (Diathesis) 03/2018
1	Thrombosis (Thrombus) 03/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018
1	Lactic Acidosis 01/2018

3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
2	axicabtagene ciloleucelIBA 12/2021 - 01/2021
2	tisagenlecleucelIBA 12/2021 - 01/2021
1	FluoroquinolonesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	CytokinesIBA 12/2021
1	C-Reactive ProteinIBA 12/2021
1	Ferritins (Ferritin)IBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	SteroidsIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 07/2020
1	Tyrosine Kinase InhibitorsIBA 08/2019
1	Hemostatics (Antihemorrhagics)IBA 03/2018
1	Prothrombin (Factor II)IBA 03/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018

2	Therapeutics 08/2023 - 01/2021
1	Length of Stay 01/2021
1	Vena Cava Filters (Inferior Vena Cava Filter) 03/2018
1	Drug Therapy (Chemotherapy) 01/2018